The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs: 👉http://ow.ly/70he50KOSG1👈 #MPNsm #HemOnc #BloodCancerAwarenessMonth
First session tomorrow! (How time flies…..) https://twitter.com/lymphoma_soph/status/1573994220594941957
Are you a registrar looking to learn the evidence base for the diagnosis & management of #lymphoma? Or a consultant/nurse looking for an update to your knowledge around research & practice? #LymphomaManagement Course is for you! > http://lymphoma-action.org.uk/LymphomaManagement @graham74GC @tobyeyre82
We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP: 🎥: http://ow.ly/ibfm50KOSf3 @Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth
We're pleased to bring you another podcast! 🤩 Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population. 🎧: http://ow.ly/2Top50KQC0l #MMsm #HemOnc #ImmunoOnc
Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩⚕️👨⚕️ You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more! @SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm
Explore our coverage of real-world data across a spectrum of hematological diseases.
The latest results from the key trials at ASH 2020.
Watch experts explain the data from cutting-edge research.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter